Jürgen Kuball, MD, PhD, Utrecht University, Utrecht University, Netherlands, gives a summary of his talk on toxicities associated with chimeric antigen receptor T-cell (CAR-T) therapies, highlighting challenges around data collection and analysis. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.